Skip to Main Content

Paper Details

Potent platelet inhibition with peri-procedural tirofiban may attenuate progression of atherosclerosis in patients with acute coronary syndromes.
J Thromb Thrombolysis
0
2022
Author NameAffiliation
Hang LeeMassachusetts General Hospital, Harvard Medical School
  • 1 - 1

Datasets

Release 1.2